Also known as: Ebola virus disease (EVD), Ebola haemorrhagic fever (Ebola HF)
Classification: Virus
Industry of interest: Healthcare
Microbiology: Ebola is an enveloped RNA virus from the Filoviridae family (Lee and Henderson 2001; Ftika and Maltezou 2013). It is classified as Biosafety Level / Containment Level 4, meaning that it should only be handled in high-containment laboratories.
Habitat and transmission: Ebola virus disease (EVD) was first reported near the Ebola river in the Democratic Republic of Congo in 1976, which is where the virus gets its name from. Ebola enters the human population through close contact with the blood, secretions, organs or other bodily fluids of infected animals . Human to human transmission occurs through either direct contact with blood or body fluids (through broken skin or mucous membranes) or indirect contact with contaminated environments (Lee and Henderson 2001; Bausch, Towner et al. 2007; Ftika and Maltezou 2013).
Read moreDisease and symptoms: EVD is a viral haemorragic fever (VHF), which is characterised sudden onset of fever, intense weakness, muscle pain, headache and sore throat (Clark, Jahrling et al. 2012). This is followed by vomiting, diarrhoea, and sometimes internal and external bleeding. The incubation period is 2-21 days.
Treatment: There is no effective drug to treat Ebola. Therefore, management of infected patients relies on supportive care, including rehydration (Clark, Jahrling et al. 2012).
References:
Bausch, D. G., J. S. Towner, et al. (2007). "Assessment of the risk of Ebola virus transmission from bodily fluids and fomites." J Infect Dis 196 Suppl 2: S142-147.
Clark, D. V., P. B. Jahrling, et al. (2012). "Clinical management of filovirus-infected patients." Viruses 4(9): 1668-1686.
Ftika, L. and H. C. Maltezou (2013). "Viral haemorrhagic fevers in healthcare settings." J Hosp Infect 83(3): 185-192.
Lee, L. M. and D. K. Henderson (2001). "Emerging viral infections." Curr Opin Infect Dis 14(4): 467-480.
Sales
01264835835
Technical support
+44 (0)1264 252 104
General enquiries
+44 (0)1264 835 835
+44 (0)1264 835 836
info@bioquell.com
Bioquell UK Ltd
52 Royce Close
West Portway
Andover
Hampshire SP10 3TS
Use Bioquell HPV safely. Always read the label and product information before use.
